Evidence map›Paper›PMID 32472658›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2020

DNAJC6 Mutations Disrupt Dopamine Homeostasis in Juvenile Parkinsonism-Dystonia.

Joanne Ng, Elisenda Cortès-Saladelafont, Lucia Abela, Pichet Termsarasab, Kshitij Mankad, Sniya Sudhakar, Kathleen M Gorman, Simon J R Heales, Simon Pope, Lorenzo Biassoni and 15 more

Open access · hybridAbstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Roles in physiology and disease of the inositol phosphatase synaptojanin 1.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2026
    Review
  6. Review
  7. Article
  8. Genetic Sketch of Parkinson's Disease in India.Annals of Indian Academy of Neurology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 12 institutions in 5 countries.

Joanne NgMolecular Neurosciences, Developmental Neurosciences Programme, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Elisenda Cortès-SaladelafontMolecular Neurosciences, Developmental Neurosciences Programme, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Lucia AbelaMolecular Neurosciences, Developmental Neurosciences Programme, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Pichet TermsarasabDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, USA.ORCID 0000-0002-3260-3119
Kshitij MankadDepartment of Radiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
Sniya SudhakarDepartment of Radiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
Kathleen M GormanMolecular Neurosciences, Developmental Neurosciences Programme, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Simon J R HealesNeurometabolic Unit, National Hospital for Neurology and Neurosurgery, London, United Kingdom.
Simon PopeNeurometabolic Unit, National Hospital for Neurology and Neurosurgery, London, United Kingdom.
Lorenzo BiassoniDepartment of Radiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
Barbara CsányiMolecular Neurosciences, Developmental Neurosciences Programme, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
John CainDepartment of Nuclear Medicine and Imaging, Lancashire Teaching Hospitals, NHS Foundation Trust, Preston, United Kingdom.
Karl RakshiDepartment of Paediatrics, East Lancashire Hospital NHS Trust, Lancashire, United Kingdom.
Helen CouttsDepartment of Paediatrics, East Lancashire Hospital NHS Trust, Lancashire, United Kingdom.
Sandeep JayawantDepartment of Paediatric Neurology, John Radcliffe Hospital, Oxford University, NHS Foundation Trust, London, United Kingdom.
Rosalind JeffersonDepartment of Paediatrics, Royal Berkshire Hospital, NHS Foundation Trust, Reading, United Kingdom.
Deborah HughesMolecular Neuroscience and Reta Lila Weston Laboratories, Institute of Neurology, Queen Square, London, United Kingdom.
Àngels García-CazorlaDepartment of Neurology, Neurometabolic Unit and CIBERER Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain.
Detelina GrozevaMedical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
F Lucy RaymondMedical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
Belén Pérez-DueñasMolecular Neurosciences, Developmental Neurosciences Programme, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Christian De GoedeDepartment of Paediatric Neurology, Royal Preston Hospital, Lancashire Teaching Hospitals, NHS Foundation Trust, London, United Kingdom.
Toni S PearsonDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, USA.
Esther MeyerMolecular Neurosciences, Developmental Neurosciences Programme, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Manju A KurianMolecular Neurosciences, Developmental Neurosciences Programme, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Great Ormond Street Hospital · GBGreat Ormond Street Hospital for Children NHS Foundation Trust · GBEast Lancashire Hospitals NHS Trust · GBLancashire Teaching Hospitals NHS Foundation Trust · GBNational Hospital for Neurology and Neurosurgery · GBUniversity of Cambridge · GBHospital Sant Joan de Déu Barcelona · ESJohn Radcliffe Hospital · GBMahidol University · THQueen Mary University of London · GBRoyal Berkshire Hospital · GBWashington University in St. Louis · US

Funding

Department of Health RP-2016-07-019Medical Research Council MR/K02342X/1Wellcome TrustWellcome Trust WT091310
6 · The paper itself

Abstract

backgroundJuvenile forms of parkinsonism are rare conditions with onset of bradykinesia, tremor and rigidity before the age of 21 years. These atypical presentations commonly have a genetic aetiology, highlighting important insights into underlying pathophysiology. Genetic defects may affect key proteins of the endocytic pathway and clathrin-mediated endocytosis (CME), as in DNAJC6-related juvenile parkinsonism.

objectiveTo report on a new patient cohort with juvenile-onset DNAJC6 parkinsonism-dystonia and determine the functional consequences on auxilin and dopamine homeostasis.

methodsTwenty-five children with juvenile parkinsonism were identified from a research cohort of patients with undiagnosed pediatric movement disorders. Molecular genetic investigations included autozygosity mapping studies and whole-exome sequencing. Patient fibroblasts and CSF were analyzed for auxilin, cyclin G-associated kinase and synaptic proteins.

resultsWe identified 6 patients harboring previously unreported, homozygous nonsense DNAJC6 mutations. All presented with neurodevelopmental delay in infancy, progressive parkinsonism, and neurological regression in childhood.

conclusionsDNAJC6 is an emerging cause of recessive juvenile parkinsonism-dystonia. DNAJC6 encodes the cochaperone protein auxilin, involved in CME of synaptic vesicles. The observed dopamine dyshomeostasis in patients is likely to be multifactorial, secondary to auxilin deficiency and/or neurodegeneration. Increased patient CSF cyclin G-associated kinase, in tandem with reduced auxilin levels, suggests a possible compensatory role of cyclin G-associated kinase, as observed in the auxilin knockout mouse. DNAJC6 parkinsonism-dystonia should be considered as a differential diagnosis for pediatric neurotransmitter disorders associated with low homovanillic acid levels. Future research in elucidating disease pathogenesis will aid the development of better treatments for this pharmacoresistant disorder. © 2020 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

Indexed as

DystoniaParkinsonian DisordersChildDopamineHomeostasisHSP40 Heat-Shock ProteinsHumansMutationDNAJC6 protein, humanDopamineHSP40 Heat-Shock ProteinsauxilinDNAJC6dopaminedystoniaparkinsonism

Identifiers

PMID32472658
PMCPMC8425408
OpenAlexW3031205976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.